Medical AI company Coreline Soft, led by CEO Kim Jin-Guk, announced on May 12 that it has signed a distribution agreement for its proprietary artificial intelligence (AI) software ‘AVIEW LCS Plus’ with Incepto Medical, a leading European healthcare AI solutions provider. Under this agreement, Coreline Soft plans to leverage Incepto Medical’s global network to expand the overseas supply of its AVIEW products.

Coreline Soft entered into this agreement to further expand into the European market, backed by the technological competitiveness of its own AI software. AVIEW LCS Plus is a flagship product of Coreline Soft and has already demonstrated its performance by being applied in government-led lung cancer screening projects across multiple European countries.

Incepto Medical, based in France, is a specialized distributor and platform provider for AI medical imaging solutions. It operates its own AI platform to deliver integrated AI solutions to hospitals and medical institutions. By collaborating with numerous global AI companies, Incepto has successfully established a network of over 300 healthcare facilities across Europe.

With this new agreement, Coreline Soft aims to continue its collaboration with Incepto Medical and accelerate its strategy to conquer the global medical AI market. Under the partnership, Incepto Medical will distribute and sell AVIEW LCS Plus within key European countries, including France. The company expanded beyond Europe by establishing a US subsidiary last year and plans to extend its cooperation further into the North American market, including the US, the company explained.

Kim Jin-Guk, CEO of Coreline Soft, stated, “Our products are being adopted in government-led projects in various European countries, and we are receiving numerous supply requests from local companies. We have decided to collaborate with Incepto Medical, which holds a leading position in the healthcare AI industry in Europe,” adding, “This agreement has laid the foundation for expanding our market reach from Europe to the US.” He remarked, “Incepto Medical’s established local healthcare networks and collaborations with various global AI firms are expected to boost the supply of AVIEW LCS Plus significantly. Moving forward, we will continue to partner with global companies to maximize market share for our AI software, which demonstrates world-class technology.”

Meanwhile, Coreline Soft will participate in the 2025 Société d’Imagerie Thoracique (SIT) conference, Europe's premier thoracic radiology event, to be held in Marseille, France, on the 23rd and 24th. 

Incepto Medical, founded in France in 2018, is a specialized company in healthcare AI solution integration and distribution. It supplies AI-based imaging diagnostic software to hospitals and radiology centers across Europe. Through its own platform, Incepto offers a variety of integrated AI solutions, focusing on optimizing clinical workflows in medical settings.

Yeon Choul-woong 다른기사 보기